Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Transplantation
Reference53 articles.
1. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005;Altekruse;J Clin Oncol,2009
2. MELD exceptions and rates of waiting list outcomes;Massie;Am J Transplant,2011
3. Statistical aspects of the analysis of data from retrospective studies of disease;Mantel;J Natl Cancer Inst,1959
4. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability;Schuirmann;J Pharmacokinet Biopharm,1987
5. Surgical management of early-stage hepatocellular carcinoma: resection or transplantation?;Bellavance;J Gastrointest Surg,2008
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multidisciplinary treatment of hepatocellular carcinoma in 2023: Italian treatment guidelines;Hepatoma Research;2024-05-30
2. Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) – Part I – Surgical treatments;Digestive and Liver Disease;2024-02
3. Survival impact of pre-transplant local treatments in liver transplant recipients with BCLC stage A hepatocellular carcinoma;American Journal of Cancer Research;2024
4. Surgical Treatment of Hepatocellular Carcinoma: Multicenter Competing-risk Analysis of Tumor-related Death Following Liver Resection and Transplantation Under an Intention-to-treat Perspective;Transplantation;2023-08-21
5. Expression of mTOR in normal and pathological conditions;Molecular Cancer;2023-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3